Livedoid vasculitis responding to PUVA therapy

International Journal of Dermatology
J C LeeY K Park

Abstract

Livedoid vasculitis is a chronic disorder manifested as recurrent, painful, reticulated, and ulcerative lesions of the legs, which result in ivory atrophic scars with peripheral telangiectasia and hyperpigmentation. Its etiology remains obscure and therapy is difficult. In this study, we evaluated the clinical efficacy of psoralen plus UVA (PUVA) therapy and its side-effects in the treatment of livedoid vasculitis. Eight South Korean patients with livedoid vasculitis were treated with UVA and 8-methoxypsoralen (8-MOP). Systemic PUVA was started with 4 J/cm2 of UVA two or three times a week, and then the dose was increased by 0.5 or 1 J/cm2 increments at each subsequent treatment as tolerated. The effects of treatment were evaluated using photographs of before, during, and after the study. All patients experienced rapid cessation of new lesion formation, significant symptom relief, and complete healing of primary lesions. The mean times for each of the above were 3.6, 5.9, and 10 weeks, and the mean cumulative doses of UVA for each of the above were 55.9, 96.8, and 197.9 J/cm2, respectively. The patients tolerated PUVA therapy well without unacceptable side-effects. We propose that systemic PUVA using 8-MOP should be investigate...Continue Reading

References

Feb 1, 1975·Archives of Dermatology·A L SchroeterR E Jordan
Jan 1, 1992·Clinical and Experimental Dermatology·C S McCalmontH Rothberger
Oct 1, 1992·Mayo Clinic Proceedings·K L Klein, M R Pittelkow
May 1, 1988·Archives of Dermatology·W M Sams
Aug 1, 1986·Archives of Dermatology·K G Heine, G W Davis
Jun 1, 1973·Archives of Dermatology·J F WalterE A Duell
May 1, 1974·Archives of Dermatology·J N GilliamS D Prystowsky
Aug 1, 1983·The Journal of Investigative Dermatology·M L KripkeJ A Parrish
Jun 1, 1983·Journal of the American Academy of Dermatology·J K ShornickJ N Gilliam
Jan 1, 1997·Dermatology : International Journal for Clinical and Investigative Dermatology·G H Hsiao, H C Chiu
Feb 20, 1999·Journal of the American Academy of Dermatology·H J Choi, S K Hann
Feb 1, 1956·Circulation·M FELDAKERR R KIERLAND
Jul 1, 1955·A.M.A. Archives of Dermatology·M FELDAKERR R KIERLAND

❮ Previous
Next ❯

Citations

Dec 19, 2013·Anais Brasileiros De Dermatologia·Mariana Quirino TuboneGabriela Maldonado
Jul 16, 2014·Journal of the American Academy of Dermatology·Babak MonshiKlemens Rappersberger
Sep 14, 2013·Journal of the American Academy of Dermatology·Afsaneh AlaviRobert S Kirsner
Dec 28, 2010·Autoimmunity Reviews·Paulo Ricardo CriadoJozélio Freire de Carvalho
Feb 19, 2008·Journal of the American Academy of Dermatology·Mark D P Davis, Waldemar E Wysokinski
May 13, 2005·Photodermatology, Photoimmunology & Photomedicine·C TuchindaH W Lim
Sep 27, 2003·The British Journal of Dermatology·C-H YangL-C Yang
Jun 30, 2012·Dermatologic Therapy·Tania M Gonzalez-Santiago, Mark D P Davis
Jun 15, 2016·Indian Journal of Dermatology, Venereology and Leprology·Biju VasudevanRajesh Verma
May 4, 2005·The International Journal of Lower Extremity Wounds·Susan M CooperSusan M Burge
Oct 23, 2003·Muscle & Nerve·Cory TothDouglas Zochodne
Oct 18, 2014·Advances in Skin & Wound Care·Afsaneh AlaviRobert S Kirsner
Dec 8, 2011·Anais Brasileiros De Dermatologia·Paulo Ricardo CriadoCidia Vasconcellos
Jan 26, 2006·The British Journal of Dermatology·W-H JuanC-H Yang
Nov 6, 2021·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Marie-Luise SchiffmannTobias Goerge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Autoimmunity Reviews
P R CriadoJozélio Freire de Carvalho
The Journal of Pediatrics
S M Suarez, A S Paller
Photodermatology, Photoimmunology & Photomedicine
C TuchindaH W Lim
© 2021 Meta ULC. All rights reserved